Reviewed Mar 2026 | Sources: PubMed

AOD-9604 vs Ipamorelin: Head-to-Head Comparison

AOD-9604 is an hGH fragment (176-191) that was designed to isolate fat-burning effects of GH without other GH activity, while ipamorelin stimulates natural GH release for full-spectrum GH benefits. AOD-9604 failed clinical trials for obesity, while ipamorelin shows consistent GH elevation in studies.

Side-by-Side Comparison

DimensionAOD-9604Ipamorelin
Evidence LevelFailed Phase IIb/III trials for obesityPhase II trials showing consistent GH release
FDA StatusNot approvedNot approved
MechanismhGH fragment targeting lipolysis without IGF-1Ghrelin receptor agonist stimulating natural GH pulses
Body Composition EffectFailed to demonstrate efficacy in trialsGH elevation supports fat loss and lean mass
Side EffectsMinimal reportedMinimal; no cortisol/prolactin impact
GH/IGF-1 ImpactDoes not raise GH or IGF-1Raises GH and IGF-1 levels
CostLowModerate
Evidence Level
AOD-9604
Failed Phase IIb/III trials for obesity
Ipamorelin
Phase II trials showing consistent GH release
FDA Status
AOD-9604
Not approved
Ipamorelin
Not approved
Mechanism
AOD-9604
hGH fragment targeting lipolysis without IGF-1
Ipamorelin
Ghrelin receptor agonist stimulating natural GH pulses
Body Composition Effect
AOD-9604
Failed to demonstrate efficacy in trials
Ipamorelin
GH elevation supports fat loss and lean mass
Side Effects
AOD-9604
Minimal reported
Ipamorelin
Minimal; no cortisol/prolactin impact
GH/IGF-1 Impact
AOD-9604
Does not raise GH or IGF-1
Ipamorelin
Raises GH and IGF-1 levels
Cost
AOD-9604
Low
Ipamorelin
Moderate

Peptide Overviews

AOD-9604

CPreclinical

AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) originally developed for obesity treatment. It received GRAS status from the FDA for use in food products.

Weight LossNot Approved
View full AOD-9604 profile →

Ipamorelin

BHuman Studies

Ipamorelin is a selective growth hormone secretagogue that stimulates growth hormone release from the pituitary gland without significantly affecting cortisol or prolactin levels.

Growth Hormone SecretagoguesNot Approved
View full Ipamorelin profile →

AOD-9604 vs Ipamorelin: FAQ

Stay Informed on Peptide Research

Get weekly comparison updates, new study alerts, and regulatory changes.

No spam. Unsubscribe anytime.

Medical Disclaimer

This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations.

Always consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Do not disregard professional medical advice based on information found on this site.

No claims of therapeutic efficacy are made for substances that are not FDA-approved for the discussed indications. Research citations reflect published findings and do not imply endorsement.